Liaoning | Jilin | Zhejiang | Guangxi | Total | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Criterion | N | Per cent | N | Per cent | N | Per cent | N | Per cent | N | Per cent | p Value |
Total CVD high-risk subjects | 6712 | 26.85 | 8961 | 35.84 | 5269 | 21.08 | 5957 | 23.83 | 26 899 | 26.90 | <0.001 |
CVD disease | 1225 | 18.25 | 3061 | 34.16 | 347 | 6.59 | 968 | 16.25 | 5601 | 20.82 | <0.001 |
High blood pressure | 4898 | 72.97 | 5774 | 64.43 | 4156 | 78.88 | 3481 | 58.44 | 18 309 | 68.07 | <0.001 |
Dyslipidaemia | 1569 | 23.38 | 1857 | 20.72 | 1045 | 19.83 | 2340 | 39.28 | 6811 | 25.32 | <0.001 |
WHO risk ≥20% | 1817 | 27.07 | 2125 | 23.71 | 1450 | 27.52 | 1614 | 27.09 | 7006 | 26.05 | <0.001 |
No risk | 18 288 | 73.15 | 16 039 | 64.16 | 19 731 | 78.92 | 19 043 | 76.17 | 73 101 | 73.10 |
χ2 tests for proportion, α=0.05.
CVD, cardiovascular disease.